Previsioni di mercato dei test sviluppati in laboratorio per Medio Oriente e Africa fino al 2028: impatto del COVID-19 e analisi regionale per tipologia (biochimica clinica, terapia intensiva, ematologia, microbiologia, diagnostica molecolare, immunologia e altri tipi di test) e applicazione (istituti accademici, ricerca clinica) organizzazioni, laboratori ospedalieri, centri diagnostici specialistici e altri)
Introduzione al mercato
Un test sviluppato in laboratorio (LDT) è un tipo di test diagnostico in vitro progettato e utilizzato all\'interno un unico laboratorio. Questi test possono essere utilizzati per stimare o distinguere un vasto assortimento di materiali di analiti come proteine, composti chimici come glucosio o colesterolo o DNA, da un campione ricevuto dall\'anatomia umana. Si prevede che l\'espansione dei metodi di diagnostica in vitro automatizzata (IVD) per laboratori e dispensari per eseguire analisi precise e prive di errori alimenterà l\'incremento.
Panoramica e dinamiche del mercato
Si prevede che il mercato dei test sviluppati in laboratorio in Medio Oriente e Africa raggiungerà gli Stati Uniti 869,59 milioni di dollari entro il 2028 da 577,05 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 7,0% dal 2021 al 2028. La continua ricerca sulla medicina personalizzata e la crescente automazione dei processi di laboratorio in tutto il mondo sono fattori che spingono il mercato dei test sviluppati in laboratorio. Tuttavia, il mutevole panorama normativo sta ostacolando la crescita del mercato dei test di sviluppo di laboratorio in Medio Oriente e Africa.
Le LDT svolgono un ruolo vitale nello sviluppo di farmaci personalizzati che probabilmente si riveleranno un mezzo promettente per affrontare le malattie attraverso trattamenti o cure efficaci finora sfuggiti. Secondo la Personalized Medicine Coalition, i farmaci personalizzati rappresentavano solo il 5% delle nuove entità molecolari approvate dalla FDA nel 2005; tuttavia, nel 2016, questo numero è salito a oltre il 25%. Inoltre, il 42% di tutti i composti e il 73% dei composti oncologici in cantiere hanno il potenziale per fungere da farmaci personalizzati. Negli ultimi cinque anni le aziende biofarmaceutiche hanno quasi raddoppiato i loro investimenti in ricerca e sviluppo in farmaci personalizzati in tutto il mondo. Si prevede inoltre che aumenteranno i loro investimenti del 33% nei prossimi cinque anni. I ricercatori biofarmaceutici prevedono inoltre un aumento del 69% nello sviluppo di farmaci personalizzati nei prossimi cinque anni. Le medicine personalizzate stanno diventando il marchio di fabbrica del trattamento del cancro; si tratta di un approccio costantemente emergente basato sulla personalizzazione dei trattamenti in base alla struttura genetica individuale. Nel 2019, la FDA ha approvato 12 farmaci personalizzati per indagare e affrontare le cause profonde delle malattie, combinando così la medicina di precisione con l’assistenza clinica. La crescente domanda di medicina personalizzata offre quindi significative opportunità di crescita per gli attori che operano nel mercato dei test sviluppati in laboratorio MEA. Inoltre, l\'automazione sta emergendo come approccio per ridurre al minimo il coinvolgimento umano nei processi di laboratorio, stimolando la crescita del mercato.
Le incertezze economiche e i conflitti in corso stanno peggiorando la condizione in Medio Oriente. Ad esempio, paesi come Siria, Libia e Yemen stanno soffrendo violenti conflitti e non sono in grado di attuare alcuna misura di sanità pubblica. Un improvviso calo della domanda interna ed esterna di beni e prodotti, in particolare di petrolio greggio, e l’interruzione della produzione a causa della carenza di manodopera sono impatti significativi osservati nella regione. Inoltre, le rigide condizioni finanziarie stanno diminuendo le attività economiche in Medio Oriente. Ciò ha avuto un impatto negativo sulla crescita dei test sviluppati in laboratorio nella regione.
Mercato chiave Segmenti
Il mercato dei test sviluppati in laboratorio in Medio Oriente e Africa, per tipologia, è segmentato in biochimica clinica, terapia intensiva, ematologia, microbiologia, diagnostica molecolare, immunologia, e altri tipi di test. Il segmento ematologico è stato suddiviso in coagulazione ed emostasi, test dell\'emoglobina, test dell\'emocromo e altri. Il segmento della diagnostica molecolare ha detenuto la quota maggiore del mercato nel 2021. Tuttavia, si prevede che il segmento dell\'ematologia registrerà il CAGR più elevato durante il periodo di previsione.
Medio Oriente e Africa Il mercato dei test sviluppati in laboratorio, per applicazione, è segmentato in istituti accademici, organizzazioni di ricerca clinica, laboratori ospedalieri, centri diagnostici specializzati e altri. Il segmento dei laboratori ospedalieri ha detenuto la quota maggiore del mercato nel 2021. Tuttavia, si prevede che il segmento dei centri diagnostici specialistici registrerà il CAGR più elevato durante il periodo di previsione.
Principali fonti e aziende elencate
Alcune delle Le fonti primarie e secondarie a cui si fa riferimento durante la preparazione del rapporto sul mercato dei test sviluppati in laboratorio in Medio Oriente e Africa sono la South Africa Medical Devices Association (SAMED), la SA Health Products Regulatory Authority (SAHPRA) e l\'Agenzia internazionale per la ricerca sul cancro (IARC). /span>
Motivi per acquistare il rapporto
- Determinare potenziali aree di investimento sulla base di un\'analisi dettagliata delle tendenze del mercato di prova sviluppato in laboratorio del Medio Oriente e dell\'Africa nei prossimi anni.
- Acquisire una comprensione approfondita dei fattori sottostanti che guidano la domanda di diverse terapeutiche per la dipendenza segmenti nei paesi con la maggiore spesa e identifica le opportunità offerte da ciascuno di essi.
- Rafforza la tua conoscenza del mercato in termini di fattori trainanti della domanda, tendenze del settore e gli ultimi sviluppi tecnologici, tra gli altri.
- Identificare i principali canali che guidano il mercato dei test sviluppati in laboratorio in Medio Oriente e Africa , fornendo un quadro chiaro delle opportunità future che aiuterà ad analizzare, con conseguente espansione delle entrate.
- Canalizzare le risorse concentrandosi sui programmi in corso intrapresi dal diversi paesi all\'interno del mercato dei test sviluppati in laboratorio in Medio Oriente e Africa.
< span>
IL LABORATORIO DEL MEDIO ORIENTE E DELL\'AFRICA HA SVILUPPATO LA SEGMENTAZIONE DEL MERCATO DEI TEST
Per tipo
- Biochimica clinica
- Area critica
- Ematologia
- Coagulazione ed emostasi,
- < span>Esame dell\'emoglobina
- Emocromo
- Altro
- Immunologia
- Microbiologia
- Diagnostica molecolare
- Altri tipi di test
Di Applicazione
- Istituti accademici
- Organizzazioni di ricerca clinica
- Laboratori ospedalieri
- Centri diagnostici specialistici
- Altri
Per paese
- Emirati Arabi Uniti
- Arabia Saudita
- Sudafrica
- Resto del Medio Oriente e dell\'Africa
Profili aziendali
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Laboratory Developed Test Market – By Type
1.3.2 Middle East and Africa Laboratory Developed Test Market – By Application
1.3.3 Middle East and Africa Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Middle East and Africa Analysis
6.1 Middle East and Africa Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Middle East and Africa Analysis
9.1 Middle East and Africa: Laboratory Developed Test Market
9.1.1 Overview
9.1.2 Middle East & Africa: Laboratory Developed Test Market- Revenue and Forecast to 2028 (US$ Million)
9.1.3 Middle East and Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.3.1 Middle East and Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.4 Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5 Middle East and Africa: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.5.1 Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 Saudi Arabia Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2.1 Saudi Arabia: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.1.3 Saudi Arabia Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.2 UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 UAE Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2.1 UAE: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.2.3 UAE Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.3 South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 South Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2.1 South Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.3.3 South Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.4 Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.1 Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.2 Rest of Middle East and Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.4.2.1 Rest of Middle East and Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.4.3 Rest of Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East and Africa Laboratory Developed Test Market
10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.6 Rosetta Genomics Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 The company’s financial information is not available in the public domain.
12.6.6 SWOT Analysis
12.6.7 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East and Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 17. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 18. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Middle East and Africa Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Middle East and Africa Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Middle East and Africa Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Middle East and Africa: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Middle East & Africa Laboratory Developed Test Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East and Africa: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 24. Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.